“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

Visitors to Samsung Electronics’ booth at the Radiological Society of North America’s (RSNA) 2016 annual meeting in Chicago examine the GM85 mobile digital radiography (DR) system.

Samsung Electronics showcases the GM85 Digital Radiography (DR) system which received 510(k) FDA clearance November 17 for the US market, at the Radiological Society of North America (RSNA) 2016 Annual Meeting at McCormick Place in Chicago. At RSNA booth #4735 (South Building, Hall A), Samsung demonstrates the ultimate driving experience for radiologists and technicians by offering the “GM85 Driving Event”.

“Celebrating our fifth year participating at RSNA, the largest radiology meeting, we would like to thank our valued customers and partners for their ongoing trust and support of our medical imaging innovations,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Listening to our customers’ needs and acting swiftly to fulfill them has led to Samsung’s fast growth in radiology.”

Visitors to Samsung Electronics’ booth at the Radiological Society of North America’s (RSNA) 2016 annual meeting in Chicago examine the GM85 mobile digital radiography (DR) system.

Along with the GM85, Samsung will showcase a wide range of medical imaging solutions from premium mobile digital X-ray to advanced ultrasound systems. Moreover, new clinical research showing how Samsung’s latest ultrasound technology drives better patient care will be presented at its RSNA Corporate Symposium session Monday 8:30 a.m. – 10:00 a.m. in Room S101AB. Register to attend here.

“Our products continue to prove their versatility as more healthcare providers find new innovative ways to use them,” said Philip Sullivan, Samsung NeuroLogica President and CEO. “RSNA is a great venue for radiologists to learn the diverse ways we are helping hospitals, clinicians and patients.”

Visitors were also given a chance to experience the mobile DR system for themselves.

On display at Samsung’s booth are the following technologies:

Digital Radiography (DR)

GM85 [FDA 510(k) cleared November 17, 2016]

• Easy Navigating with Compact Design: With 555mm narrow width and weighing in at a light 349kg, the GM85 allows easy access around tight spaces, even in elevators. A collapsible column gives users clear visibility when moving the system and broadens access to smaller spaces. Adaptive soft-driving control and front-bumper sensor also help make navigation safer.
• Optimized Workflow with Enhanced Usability: SID (Source to Image Distance) Guide supports detailed device positioning with multiple SID settings. S-Align displays the detector’s angle to the THU (Tube Head Unit) for precise alignment to enhance image quality. Quick-positioning allows handle-free, precise body movement by simple button clicks on the THU and optimizes workflow, enabling users to save time.
• Advanced Imaging Technology for Superior Image Quality: S-Vue, the advanced imaging engine, enhances image sharpness and clarity. SimGrid provides high-quality images without using a conventional grid, reducing scatter radiation effects. Also, radiographers can lower retake rates as S-Vue eliminates alignment errors that often occur with a conventional grid.

GC85A (Advanced Applications) adds new features to radiography workflows:

• Fast Stitching: Our upgraded stitching technology reduces process time by 31% compared to the original GC85A. Increased process speed means radiographers receive exam images more quickly. Fast stitching helps lessen the burden on patients who find it difficult to stand for an extended period of time and leave the x-ray room faster than before.
• SimGrid: This feature streamlines workflow because it operates without a portable grid, reducing operator wrist overload. SimGrid also eliminates alignment errors that often occur with portable grids, reducing retake rates and increasing patient satisfaction.
• Bone Suppression: Clarity of soft tissue is improved when suppressing the appearance of bones in chest images.

The booth showcased 8 examples of the GM85 mobile digital radiography (DR) system for users’ examination.

Portable Computed Tomography (CT)

The BodyTom and CereTom portable systems continue to prove their versatility as they are increasingly adopted and utilized in a wide range of market applications such as mobile stroke units, brachytherapy suites and proton therapy centers, deep brain stimulation and even veterinarian hospitals.

CereTom receives accolades as more mobile stroke treatment units implement the CT scanner:

• The use of CereTom-equipped mobile stroke units expands to several new cities, including New York City, Chicago, and Trenton, New Jersey
• CereTom was awarded a showcase spot among 14 medical innovations before thousands of hospital executives at Premier Inc.’s Annual Innovation Celebration during the company’s 2016 Breakthroughs Conference and Exhibition June 21 for healthcare providers.

BodyTom expands into new care paths as radiologists find more value:

• The University of Texas MD Anderson Cancer Center in Houston, Texas added BodyTom® CT, the world’s first portable, full-body, 32-slice CT (computed tomography) scanner to its Proton Therapy Center and is now treating patients at the facility using images from the scanner.
• The University of Wisconsin (UW) Carbone Cancer Center in Madison recently incorporated BodyTom® technology into its radiation oncology brachytherapy planning process.
• Willis-Knighton Cancer Center in Shreveport, La., also added BodyTom® CT to its brachytherapy suite.

The booth also included an ambulance equipped with Samsung Electronics’ acclaimed CereTom portable computed tomography (CT) scanner – a versatile system utilized in mobile stroke units and a range of other emergency applications.

Ultrasound

RS80A with Prestige – live scanning demos at our RSNA booth – offers cutting-edge features:

• CEUS+: On the heels of the recent FDA approval of contrast-enhanced ultrasound for liver lesions in adults and pediatrics, Samsung introduces its latest contrast-enhanced ultrasound imaging, CEUS+. The RS80A premium ultrasound system applying sophisticated imaging technology that empowers user’s confident diagnosis. The superb resolution and improved uniformity help users acquire better clarity in the near field. Its automatic brightness-control feature optimizes imaging in real-time, providing users with enough time to diagnose. The CEUS+ also improves the diagnosis of small lesions, and its clear expression of tissue boundaries helps users to achieve interventional procedures with ease and accuracy.
• S-Detect^TM for Breast [pending FDA 510(k) clearance, not yet available in the U.S.] – Applying data from 10,000 breast exams to ultrasound imaging, S-Detect helps radiologists understand characteristics of breast lesions to determine whether they’re malignant or benign in a few clicks. The S-Detect^TM provides faster and more accurate results by adopting a big-data, deep-learning algorithm in lesion segmentation, characteristic analysis and assessment processes.

A Samsung representative explains the intricacies of the contrast-enhanced CEUS+ ultrasound imaging system, which provides clear and uniform images for more accurate diagnoses.

For more information on Samsung’s global medical imaging technologies, please visit www.samsungmedicalsolution.com. At RSNA visit booth #4735 (South Building, Hall A) and stay up-to-date by following the Samsung NeuroLogica Twitter feed @SamsungHealthUS.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of computed tomography, is also the U.S. headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit http://www.SamsungNeuroLogica.com.

Samsung Electronics will be participating in this year’s Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), the world’s largest radiology conference, to unveil its latest innovations and contributions in healthcare.

Come visit us at Chicago’s McCormick Place (South Hall A: #4735) from November 27 to December 2.

For the latest information about Samsung’s healthcare events, please follow the link below:

http://samsungmedicalsolution.com/en/common/eventViewList

For a sneak peek into our latest radiology product please follow the link below:

http://gm85.samsungmedicalsolution.com/